Acute Tubular Necrosis & Interstitial Nephritis

Notes

Acute Tubular Necrosis & Interstitial Nephritis

Sections




Overview

  • These are intrarenal pathologies.
  • Both conditions can cause acute kidney injury, which is characterized by increased creatinine and decreased urine volume.

Acute tubular necrosis (ATN)

Tubule necrosis leads to impaired filtration and increased NaCl delivery to the macula densa.

As a result, the tubuloglomerular feedback mechanism of GFR regulation is activated, and GFR is reduced. Recall that reduced GFR can lead to azotemia and uremia (see the links in our notes for more information).

Acute tubular necrosis can be caused by low blood flow to the kidneys or exposure to toxic substances.

Ischemic causes include hypotension, surgery, and sepsis; essentially, any event that contributes to pre-renal acute kidney injury can also contribute to acute tubular necrosis.

Be aware that, in addition to hemodynamic effects, sepsis also has detrimental inflammatory effects on the tubules.

Toxins:

Several endogenous and exogenous toxins can damage the renal tubules.

  • Excessive quantities of myoglobin and hemoglobin damage the tubules via direct and indirect mechanisms (for example, we see ATN in rhabdomyolysis and massive hemolysis).
  • Iondated radiocontrast agents used in imaging technologies tend to cause self-limited and reversible elevations in serum creatinine, but long-term renal and/or cardiovascular problems can occur.
  • Contrast nephropathy usually appears within 24-72 hours of administration.
  • Hyperuricemia, as we see in patients with tumor lysis syndrome and gout, induces inflammatory reactions in the tubules.
  • Various poisons, including ethylene glycol and mercury, trigger tubular necrosis.
  • Several drugs, including aminoglycosides, vancomycin, chemo drugs, and NSAIDs, are toxic to the renal tubules.

Stages of ATN:

  1. The inciting event (ischemia or necrosis).
  2. Maintenance phase, which comprises 1-3 weeks of oliguria with declining renal functioning.
  3. Recovery phase, which is characterized by polyuria with falling serum creatinine and BUN.

Risk factors: ATN is a common cause of renal failure in older patients, those with other kidney diseases and/or diabetes, and those who are hospitalized with other critical illnesses.

Diagnosis:
In the urine, we look for muddy brown casts and renal tubular epithelial cells.

FENa > 2% (except in the case of contrast nephropathy, which is often < 1%).

Treatments: There are no specific treatments for acute tubular necrosis, but we can give patients supportive care with fluid and electrolytes, and, when possible, address the root causes (correct the hemodynamic imbalance, remove exposure to toxins).

Histopathology: Focal necrosis and apoptosis, with cells and cellular debris in the tubule lumens; may also see increased mitotic activity in tubules undergoing repair. Tubules have wide, cluttered lumens with smaller tubule cells and ragged edges.

Histopathology may reflect the specific etiology:

When excessive hemoglobin or myoglobin is the cause, we see red-brown casts in the distal and collecting tubules.
In mercury poisoning, we see large acidophilic inclusions.
In ethylene glycol poisoning, we see calcium oxalate crystals.

(Tubulo-) Interstitial Nephritis

Aka, tubulointerstitial nephritis when the tubules are also involved.

Renal interstitium supports the tubules, produces hormones, and helps regulate fluid and electrolyte balance.

Medications, infections, autoimmune disorders, and specific genes can cause inflammation in the interstitium.

Inflammatory cells infiltrate the renal interstitium and impair tubular functioning and reduce GFR.

Medications: Interstitial nephritis is most commonly caused by allergic drug reactions to drugs: NSAIDs, beta-lactams, diuretics, proton pump inhibitors, anti-cancer drugs, and several others. These drugs act as haptens and bind to tubular cell components and trigger an immune response (in other words, they cause hypersensitivity reactions).

Be aware that interstitial nephritis is apparent 1-3 weeks after most medications, but the timeframe varies by drug.

**Infections & other disorders ** including Legionella, CMV, Streptococcus (plus several others); Sarcoidosis and SLE.

Signs/Symptoms: the "classic triad" of signs and symptoms consists of rash, fever, and eosinophilia; however, it's rare to see all three manifestations at once, and patients may have pyuria or hematuria.

Diagnosis: Urine - sterile pyuria, eosinophiluria, white blood cell casts, and proteinuria; we can also look for characteristic histopathology after biopsy.

Treatment: There's no specific treatment, so we remove the drug or treat the causative illness.

Histopathology: Characterized by interstitial edema with white blood cell infiltration; granuloma formation is also possible. Note that the condition can become chronic, in which case we might see fibrosis, scarring, and atrophy.

Board Review

Acute Tubular Necrosis

Getting ready for boards? Review these concise, bulleted high yield reviews for your exam.

USMLE & COMLEX-USA

Nurse Practitioner (NP)

Physician Assistant (PA)

Internal Medicine (ABIM)

References

  • Ali, Asad, Chandur Bhan, Muhammad Bilal Malik, Malik Qistas Ahmad, and Shahzad Ahmed Sami. "The Prevention and Management of Contrast-Induced Acute Kidney Injury: A Mini-Review of the Literature." Cureus 10, no. 9 (n.d.): e3284. https://doi.org/10.7759/cureus.3284.
  • Alobaidi, Rashid, Rajit K. Basu, Stuart L. Goldstein, and Sean M. Bagshaw. "Sepsis-Associated Acute Kidney Injury." Seminars in Nephrology 35, no. 1 (January 2015): 2–11. https://doi.org/10.1016/j.semnephrol.2015.01.002.
  • Anwar, Muhammad Yasir, and Vikas Gupta. "Myoglobinuria." In StatPearls. Treasure Island (FL): StatPearls Publishing, 2022. http://www.ncbi.nlm.nih.gov/books/NBK557379/.
  • Bhandari, Jenish, Pawan K. Thada, and Hasan Arif. "Tubulointerstitial Nephritis." In StatPearls. Treasure Island (FL): StatPearls Publishing, 2022. http://www.ncbi.nlm.nih.gov/books/NBK557537/.
  • Caravaca-Fontan, Fernando a, Gema c Fernandez-Juarez, and Manuel a Praga. "Acute Kidney Injury in Interstitial Nephritis. [Miscellaneous Article]." Current Opinion in Critical Care 25, no. 6 (December 2019): 558–64. https://doi.org/10.1097/MCC.0000000000000654.
  • Merck Manuals Professional Edition. "Contrast Nephropathy - Genitourinary Disorders." Accessed September 6, 2022. https://www.merckmanuals.com/professional/genitourinary-disorders/tubulointerstitial-diseases/contrast-nephropathy.
  • Hanif, Muhammad O., Atul Bali, and Kamleshun Ramphul. "Acute Renal Tubular Necrosis." In StatPearls. Treasure Island (FL): StatPearls Publishing, 2022. http://www.ncbi.nlm.nih.gov/books/NBK507815/.
  • Hindawi. "High Serum Uric Acid Is Associated with Tubular Damage and Kidney Inflammation in Patients with Type 2 Diabetes." Accessed September 12, 2022. https://www.hindawi.com/journals/dm/2019/6025804/.
  • "Histology Clinical Correlations." Accessed September 6, 2022. https://webpath.med.utah.edu/HISTHTML/NORMAL/HCC/HCC18.html.
  • Hoenig, Melanie P., and Samir M. Parikh. "Mind the Cast: FENa versus Microscopy in AKI." Kidney360 3, no. 4 (April 28, 2022): 583–85. https://doi.org/10.34067/KID.0001212022.
  • Joyce, Emily, Paulina Glasner, Sarangarajan Ranganathan, and Agnieszka Swiatecka-Urban. "Tubulointerstitial Nephritis: Diagnosis, Treatment and Monitoring." Pediatric Nephrology (Berlin, Germany) 32, no. 4 (April 2017): 577–87. https://doi.org/10.1007/s00467-016-3394-5.
  • Koratala, Abhilash, Roohan Khan, and Xu Zeng. "Silent Acute Interstitial Nephritis: Suspicion Is the Key to Diagnosis." The American Journal of Medicine 131, no. 4 (April 1, 2018): e151–52. https://doi.org/10.1016/j.amjmed.2017.11.016.
  • Kundert, Fedor, Louise Platen, Takamasa Iwakura, Zhibo Zhao, Julian A. Marschner, and Hans-Joachim Anders. "Immune Mechanisms in the Different Phases of Acute Tubular Necrosis." Kidney Research and Clinical Practice 37, no. 3 (September 2018): 185–96. https://doi.org/10.23876/j.krcp.2018.37.3.185.
  • Maremonti, Francesca, Claudia Meyer, and Andreas Linkermann. "Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss." Journal of the American Society of Nephrology 33, no. 3 (March 2022): 472–86. https://doi.org/10.1681/ASN.2021101293.
  • Mohammed, Nazar M. A., Ahmed Mahfouz, Katafan Achkar, Ihsan M. Rafie, and Rachel Hajar. "Contrast-Induced Nephropathy." Heart Views?: The Official Journal of the Gulf Heart Association 14, no. 3 (2013): 106–16. https://doi.org/10.4103/1995-705X.125926.
  • Moledina, Dennis G., and Mark A. Perazella. "Treatment of Drug-Induced Acute Tubulointerstitial Nephritis: The Search for Better Evidence." Clinical Journal of the American Society of Nephrology 13, no. 12 (December 7, 2018): 1785–87. https://doi.org/10.2215/CJN.12001018.
  • Moledina, Dennis G., and Chirag R. Parikh. "Differentiating Acute Interstitial Nephritis from Acute Tubular Injury: A Challenge for Clinicians." Nephron 143, no. 3 (2019): 211–16. https://doi.org/10.1159/000501207.
  • Naik, Ruchi H., and Pavan Annamaraju. "Interstitial Nephritis." In StatPearls. Treasure Island (FL): StatPearls Publishing, 2022. http://www.ncbi.nlm.nih.gov/books/NBK564349/.
  • Merck Manuals Professional Edition. "Obstructive Uropathy - Genitourinary Disorders." Accessed September 7, 2022. https://www.merckmanuals.com/professional/genitourinary-disorders/obstructive-uropathy/obstructive-uropathy.
  • Merck Manuals Professional Edition. Accessed September 6, 2022. https://www.merckmanuals.com/professional/SearchResults?query=Acute+Tubular+Necrosis&icd9=584.5.
    "The Role of Uric Acid in Acute Kidney Injury - FullText - Nephron 2019, Vol. 142, No. 4 - Karger Publishers." Accessed September 12, 2022. https://www.karger.com/Article/Fulltext/499939.
  • Merck Manuals Professional Edition. "Tubulointerstitial Nephritis - Genitourinary Disorders." Accessed September 7, 2022. https://www.merckmanuals.com/professional/genitourinary-disorders/tubulointerstitial-diseases/tubulointerstitial-nephritis.
  • "Tubulointerstitial Nephritis: Practice Essentials, Pathophysiology, Etiology," June 10, 2022. https://emedicine.medscape.com/article/243597-overview.